CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 76 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $236,000 | +62.8% | 7,053 | 0.0% | 0.01% | +60.0% |
| Q1 2021 | $145,000 | +16.9% | 7,053 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $124,000 | +18.1% | 7,053 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $105,000 | +14.1% | 7,053 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $92,000 | +666.7% | 7,053 | 0.0% | 0.00% | +300.0% |
| Q1 2020 | $12,000 | -25.0% | 7,053 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | +6.7% | 7,053 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | -21.1% | 7,053 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $19,000 | -45.7% | 7,053 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $35,000 | – | 7,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 761,398 | $41,108,000 | 10.12% |
| Opaleye Management Inc. | 985,000 | $53,045,000 | 9.91% |
| VR Adviser, LLC | 1,098,174 | $59,290,000 | 7.62% |
| ACUTA CAPITAL PARTNERS, LLC | 337,500 | $18,222,000 | 6.43% |
| TSP Capital Management Group, LLC | 271,429 | $14,654,000 | 5.00% |
| Ghost Tree Capital, LLC | 255,000 | $13,767,000 | 4.03% |
| COMMODORE CAPITAL LP | 248,207 | $13,401,000 | 3.53% |
| RTW INVESTMENTS, LP | 3,908,947 | $211,044,000 | 3.18% |
| Ikarian Capital, LLC | 791,600 | $42,741,000 | 3.01% |
| Redmile Group, LLC | 3,043,298 | $164,308,000 | 2.87% |